Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.
Replimune to resubmit twice-rejected drug for approval after FDA shakeup basliginda one cikan gelisme: Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.
Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.